These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 21854251)

  • 1. Preformulation stability study of the EGFR inhibitor HKI-272 (Neratinib) and mechanism of degradation.
    Lu Q; Ku MS
    Drug Dev Ind Pharm; 2012 Mar; 38(3):307-13. PubMed ID: 21854251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aqueous stability of bupropion.
    O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
    J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The kinetics of neostigmine degradation in aqueous solution].
    Porst H; Kny L
    Pharmazie; 1985 Oct; 40(10):713-7. PubMed ID: 4080787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin.
    Motwani SK; Khar RK; Ahmad FJ; Chopra S; Kohli K; Talegaonkar S
    Anal Chim Acta; 2007 Jan; 582(1):75-82. PubMed ID: 17386477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of low concentrations of guanine-based antivirals in sucrose or maltitol solutions.
    Desai D; Rao V; Guo H; Li D; Bolgar M
    Int J Pharm; 2007 Sep; 342(1-2):87-94. PubMed ID: 17583451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and degradation profiles of Spantide II in aqueous solutions.
    Kikwai L; Babu RJ; Kanikkannan N; Singh M
    Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of hydrolysis of a novel indolocarbazole topoisomerase I inhibitor.
    Breslin D; Sato Y; Karki SB
    Eur J Pharm Sci; 2010 Mar; 39(5):291-7. PubMed ID: 20025967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
    Wong KK; Fracasso PM; Bukowski RM; Lynch TJ; Munster PN; Shapiro GI; Jänne PA; Eder JP; Naughton MJ; Ellis MJ; Jones SF; Mekhail T; Zacharchuk C; Vermette J; Abbas R; Quinn S; Powell C; Burris HA
    Clin Cancer Res; 2009 Apr; 15(7):2552-8. PubMed ID: 19318484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of BMS-753493, a novel epothilone folate conjugate anticancer agent.
    Gokhale M; Thakur A; Rinaldi F
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1315-27. PubMed ID: 23039020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of light and heat on the stability of montelukast in solution and in its solid state.
    Al Omari MM; Zoubi RM; Hasan EI; Khader TZ; Badwan AA
    J Pharm Biomed Anal; 2007 Nov; 45(3):465-71. PubMed ID: 17719198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
    Mbah CJ
    Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preformulation study of atenolol-containing solutions.. I. The pH dependence of thermostability].
    Marton S; Hatem A; Csóka G; Rácz I
    Acta Pharm Hung; 2001 Aug; 71(2):192-5. PubMed ID: 11862668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies on the aminopeptidase from Aeromonas proteolytica: a two-metal ion mechanism for peptide hydrolysis.
    Chen G; Edwards T; D'souza VM; Holz RC
    Biochemistry; 1997 Apr; 36(14):4278-86. PubMed ID: 9100023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of degradation of cefazolin and cephalexin in aqueous solution.
    Rattie ES; Guttman DE; Ravin LJ
    Arzneimittelforschung; 1978; 28(6):944-8. PubMed ID: 35181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preformulation studies of atenolol in oral liquid dosage form. I. Effect of pH and temperature.
    Hatem A; Marton S; Csóka G; Rácz I
    Acta Pharm Hung; 1996 Jul; 66(4):177-80. PubMed ID: 9043148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives. Part 1. Log k--pH profile for sulfadimidine solvolysis.
    Zajac M
    Pol J Pharmacol Pharm; 1976; 28(5):495-503. PubMed ID: 13351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of urea in solution and pharmaceutical preparations.
    Panyachariwat N; Steckel H
    J Cosmet Sci; 2014; 65(3):187-95. PubMed ID: 25043489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinetic study of rearrangement and degradation reactions of tetrathionate and trithionate in near-neutral solutions.
    Zhang H; Jeffrey MI
    Inorg Chem; 2010 Nov; 49(22):10273-82. PubMed ID: 20961089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.